Nausea, constipation, burping, reflux: practical survival guide

GLP-1 medications slow digestion by design — and that slowing has consequences. Here's what's actually happening, what usually gets better on its own, and when to call your doctor.

If you've started a GLP-1 medication — semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound) — and your stomach is making its displeasure known, you're not alone. Nausea, constipation, burping, and reflux are among the most commonly reported experiences on these medications. These symptoms aren't random. They're largely a downstream consequence of how GLP-1 drugs work: by slowing the movement of food through your digestive system. That slowing is intentional — it helps you feel full longer and blunts blood sugar spikes — but your gut has opinions about it. Most GI symptoms are manageable, and many ease as your body adapts, particularly after dose increases level off. GI side effects are also one of the leading reasons people stop these medications before they've had a chance to work. Knowing what to expect, what to try, and when to call your care team can make a real difference. This guide walks through each of the four most common GI complaints, explains what's likely happening, offers practical strategies, and helps you recognize when a symptom needs more than home management.

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. GLP-1 receptor agonists mimic this hormone, binding to receptors throughout the body — including in the gut and brain — to signal satiety, slow the emptying of the stomach, and alter how food moves through the digestive tract. Slowed gastric emptying is a feature, not a bug. When food leaves your stomach more slowly, you feel full sooner and stay full longer, and blood sugar rises more gradually after meals. These effects support both weight loss and blood sugar management. But the same mechanism that makes these medications effective is also why your digestive system can feel unsettled. Food sitting longer in the stomach, slower movement through the intestines, and changes in gut motility all have consequences — nausea, constipation, gas, and reflux among them. GI effects are often most pronounced during dose escalation, when the medication's effects on the gut are newest and strongest. Many people find that symptoms improve once they've been on a stable dose for a few weeks, though individual variability is significant. Some people have minimal GI symptoms throughout; others find them more persistent.

What we don't fully know: The precise contribution of each mechanism to each specific symptom isn't completely established in the scientific literature. The explanations below are well-supported by what we know about GI physiology, but medicine rarely offers perfect certainty at the level of individual experience.

What the evidence says

Nausea is one of the most commonly reported side effects of GLP-1 medications and is listed in the Wegovy prescribing information. It's most frequently reported during dose escalation periods. For most people, nausea ranges from mild and intermittent to noticeable but manageable. For some, it's significant enough to affect daily function or require a clinical conversation about dose adjustment.

Why it happens

When food moves more slowly out of the stomach, the stomach stays fuller longer — and prolonged fullness is a reliable nausea trigger for many people. GLP-1 receptors also exist in the brain, and central nervous system effects may contribute to nausea independently of what's happening in the gut.

Practical strategies

Eat smaller, more frequent meals. A smaller volume of food is easier for a slower-moving stomach to handle.

Eat slowly and stop before you feel full. On a GLP-1 medication, "full" can arrive quickly and intensely. Eating past that point tends to make nausea worse.

Avoid high-fat, greasy, or heavily spiced foods. These take longer to digest and can amplify nausea. This is general GI guidance; GLP-1-specific dietary studies are limited, but the principle is sound.

Don't lie down right after eating. Give your stomach time to do its work upright.

Hydrate between meals rather than during. Drinking large amounts with food adds volume to an already-slow stomach.

Consider meal timing relative to your injection. Some people find nausea peaks in the day or two after their weekly injection; adjusting when you eat during that window may help.

When to act

| What you're experiencing | What to do | |---|---| | Mild nausea that comes and goes, especially around dose increases; improving over days to a few weeks | Watch and wait; try the strategies above | | Persistent or severe nausea; difficulty keeping food down | Contact your care team | | Prolonged vomiting; signs of dehydration (dizziness, dark urine, inability to keep fluids down); nausea with severe abdominal pain | Seek urgent or emergency care |

Severe abdominal pain alongside nausea or vomiting is a reason to seek care promptly. The Wegovy prescribing information lists pancreatitis among serious potential adverse events; while uncommon, it requires evaluation.

What the evidence says

Constipation is listed as a common adverse reaction in the Wegovy prescribing information, with an incidence of 5% or greater. It's also frequently underreported — many people assume it will resolve on its own and don't mention it to their care team until it's become a real problem.

Why it happens

Like nausea, constipation traces back to slowed motility, but throughout the entire digestive tract, not just the stomach. Slower transit through the intestines means stools spend more time in the colon, where water is absorbed, making them harder and more difficult to pass. Reduced food intake — a goal of the medication — can also mean less dietary fiber, which further slows things down.

Practical strategies

Increase dietary fiber gradually. Vegetables, legumes, and whole grains all support bowel regularity. The "gradually" part matters: adding too much fiber too quickly can cause bloating and gas.

Prioritize fluids throughout the day. Fiber needs water to do its job, and dehydration makes constipation worse.

Move your body. Even regular walking supports gut motility. Consistent movement helps; a formal exercise program isn't required.

Consider an osmotic laxative if dietary changes aren't enough. Products containing polyethylene glycol (like MiraLAX) are generally well-tolerated and work by drawing water into the colon. Discuss any regular laxative use with your clinician before starting.

Avoid stimulant laxatives as a first-line or ongoing approach without clinical guidance. They work differently and aren't appropriate for routine use.

When to act

| What you're experiencing | What to do | |---|---| | Infrequent stools that respond to dietary changes and increased fluids | Watch and wait; try the strategies above | | No bowel movement for 3–4 days despite interventions; significant bloating or discomfort; need for ongoing laxative use | Contact your care team | | Severe abdominal pain; vomiting alongside constipation; signs of obstruction | Seek urgent or emergency care |

What the evidence says — and what we don't know

Burping is not explicitly listed as a common side effect in the Wegovy prescribing information. Patients on GLP-1 medications frequently report increased burping, though — including burps with a sulfur or "rotten egg" odor — and this experience is widely discussed in patient communities. The most plausible explanation connects back to slowed gastric emptying: when food sits in the stomach longer, it has more time to ferment, producing gas, including sulfur-containing compounds. This is a mechanistically reasonable explanation, but direct clinical evidence linking GLP-1 medications specifically to sulfur burp production was not available in the sources used for this article. The connection is inferred from what we know about digestion, not confirmed by clinical studies. If you're experiencing sulfur burps on a GLP-1 medication, you're not imagining it, and there's a plausible reason it's happening — but no clinical trial has confirmed the link.

Practical strategies

Eat more slowly and chew thoroughly. Swallowed air is a significant contributor to burping, and eating quickly increases it.

Avoid carbonated beverages. These add gas directly to the stomach.

Eat smaller portions. Less food in a slower-moving stomach means less fermentation load.

Identify your personal trigger foods. Foods that commonly produce sulfur gas include eggs, cruciferous vegetables (broccoli, cabbage, cauliflower), and red meat. Individual triggers vary; keeping a food log can help you spot patterns.

Peppermint tea or ginger may help some people with general gas and bloating. Evidence is limited, but both are generally safe for most people.

When to act

| What you're experiencing | What to do | |---|---| | Occasional burping, especially after meals; manageable with dietary adjustments | Watch and wait; try the strategies above | | Frequent or disruptive burping; significant bloating, nausea, or upper abdominal discomfort that doesn't improve | Contact your care team |

What the evidence says

The relationship between GLP-1 medications and acid reflux is mechanistically plausible, but not as directly established in prescribing information as nausea or constipation. Slowed gastric emptying means stomach contents — including acid — remain in the stomach longer, and increased stomach pressure may make it easier for acid to move upward into the esophagus. Comparative reflux incidence data across GLP-1 medications was not available for this article. Reflux with GLP-1 medications does not automatically indicate a serious problem; for many people, it's a manageable nuisance, not a danger signal. There's also a longer-term consideration worth noting: weight loss is associated with reduced GERD symptoms over time. As GLP-1 therapy progresses and weight decreases, reflux may actually improve, potentially offsetting any medication-related effects. This varies by individual and isn't guaranteed.

Practical strategies

Eat smaller meals. A less-full stomach has less pressure pushing upward.

Avoid eating within 2–3 hours of lying down. Gravity helps keep stomach contents where they belong.

Elevate the head of your bed if nighttime reflux is a problem. A wedge pillow or bed risers under the headboard can help; extra pillows under your head are less effective.

Identify your personal trigger foods. Common culprits include citrus, tomatoes, chocolate, caffeine, alcohol, and fatty foods, but triggers vary.

Avoid tight clothing around the abdomen. External pressure on the stomach can worsen reflux.

Over-the-counter antacids or H2 blockers may provide relief for occasional symptoms. If you're using them regularly, discuss with your clinician — both to confirm they're appropriate for you and to check for interactions with other medications.

When to act

| What you're experiencing | What to do | |---|---| | Mild, occasional heartburn that responds to dietary changes or OTC antacids | Watch and wait; try the strategies above | | Frequent or worsening reflux; symptoms not responding to OTC measures; new onset of reflux after starting medication | Contact your care team | | Difficulty swallowing; chest pain (rule out cardiac causes first); vomiting blood | Seek urgent or emergency care immediately |

A few themes run through every GI side effect on this list. Dose escalation is the highest-risk period. GI symptoms are most common and most intense when the dose is new or recently increased. Many people find that symptoms improve meaningfully once they've been on a stable dose for several weeks. If you're in the middle of a dose increase and struggling, that context matters. Slower titration is a legitimate clinical option. If GI side effects are significantly affecting your quality of life, it's entirely reasonable to ask your prescriber whether your dose escalation schedule can be slowed. This is a commonly used strategy, not a sign of failure. Don't self-manage through severe symptoms. Dietary adjustments and OTC remedies have a real role to play, but they have limits. Severe or persistent symptoms deserve a clinical conversation — earlier is better than later. Keep a simple symptom log. Note what you're experiencing, when it happens, how severe it is, what seems to help or worsen it, and how it relates to meals and injections. This information makes clinical conversations significantly more productive. Dehydration is a compounding risk. Nausea, vomiting, and constipation can all contribute to dehydration, which then makes everything worse. Prioritizing fluids — even when you don't feel like it — is one of the most important things you can do. GI side effects are a leading reason people stop GLP-1 medications before they've had a chance to work. Symptoms that feel unmanageable in isolation often become manageable with the right combination of dietary adjustments, timing changes, and clinical support.

Don't wait until symptoms are severe to bring them up. Earlier conversations lead to easier interventions. Here are specific questions worth raising:

"Is my dose escalation schedule adjustable if side effects are significant?" Yes, in most cases — but your prescriber needs to know you're struggling.

"What OTC options for constipation or reflux are safe given my full medication list?" Some interactions are worth checking.

"At what point would you recommend a dose reduction or pause?" Knowing the threshold in advance helps you make better decisions in the moment.

"Do any of my pre-existing GI conditions — gastroparesis, GERD, IBS — change the risk-benefit picture for me?" This is an individualized question that only your clinician can answer.

"What symptoms should I treat as an emergency and go to the ER rather than calling the office?" Get a clear answer to this before you need it.

Bring your symptom log to this conversation. Frequency, severity, timing relative to meals and injections — all of it helps your care team help you.

Prescribing information data draws primarily from Wegovy (semaglutide). Usable data from the Ozempic and Zepbound prescribing information were not available; incidence rates may differ across medications.

Dietary management strategies are based on general GI guidance. GLP-1-specific dietary intervention studies are limited.

Sulfur burps are discussed as mechanistically plausible, not as an established, evidence-confirmed side effect of GLP-1 medications.

Individual experience varies significantly. Timelines for symptom resolution are not predictable, and no fixed timeline is implied here.

This article is not a substitute for guidance from your prescribing clinician.

This article is editorial health information produced for general educational purposes. It is not individualized medical advice and does not establish a patient-provider relationship. It is not a substitute for consultation with a qualified healthcare provider who knows your full medical history, current medications, and individual circumstances.

If you are experiencing severe symptoms — including